Conceptual
Login

Fluconazole and Nystatin Antifungal Pharmacology

Antifungal pharmacology for candida infections is organized around drug class, indication, and toxicity profile: azole antifungals (e.g., fluconazole, ketoconazole) treat nail and skin candida infections and carry hepatotoxic risk, while nystatin treats mucocutaneous candidiasis (oral, GI, skin, vaginal) via a topical suspension. A separate class, metronidazole, treats Clostridium difficile (a bacterial, not fungal, GI infection), and amphotericin B is reserved for serious systemic fungal infections due to significant nephrotoxicity and ototoxicity. Renal function assessment (creatinine, urine output) is the central adverse-effect monitoring framework across this drug category.